Search Results 251-260 of 19330 for autoimmune hepatitis

  1. Alina M. Allen, M.D. - Doctors and Medical Staff - Mayo Clinic

    Alina Allen, M.D., has a clinical and research interest in nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

  2. Gastroenterology and Hepatology - Doctors - Mayo Clinic

    ... liver disease, Cirrhosi...s, Liver ... hepatitis, Autoimmune hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis.

  3. Liver biopsy - Doctors & Departments - Mayo Clinic

    Related. Acute liver failure · Alcoholic hepatitis · Autoimmune hepatitis · Cirrhosis · Enlarged liver · Hepatitis B · Hepatitis C · Liver cancer · Liver ...

  4. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

    This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.

  5. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

    This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.

  6. Collaborators - Genetics of Liver Disease: Kirk J. Wangensteen - Mayo Clinic Research

    Kirk J. Wangensteen, M.D., Ph.D., engages in research collaborations with other Mayo Clinic investigators.

  7. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

    This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.

  8. Hepatitis B-Associated Hepatocellular Carcinoma: Variation in Therapeutic Response Mediated by Viral Integration - Mayo Clinic Research

    Recent preliminary data have suggested that HBV-HCC may be more responsive to immunotherapy than are cancers associated with other forms of liver disease.

  9. A Study of the Frequency of Kidney Stone Formation in Liver Disease Patients - Mayo Clinic

    The purpose of this study is to compare the frequency of occurance of kidney stone formation in liver disease patients compared to the general population.

  10. Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) · Overview · Participation eligibility · Participating Mayo Clinic ...